Related by context. All words. (Click for frequent words.) 77 docetaxel 76 imatinib 74 bevacizumab 74 bortezomib 74 Rituxan 74 trastuzumab 73 cetuximab 73 gemcitabine 73 erlotinib 73 temozolomide 72 sunitinib 72 infliximab 71 adalimumab 71 Fludara 71 sorafenib 71 bendamustine 70 pemetrexed 70 Rituximab 70 monotherapy 70 anti TNF 70 decitabine 70 topotecan 70 docetaxel chemotherapy 70 CHOP chemotherapy 69 dasatinib 69 methotrexate 69 azacitidine 69 etanercept 69 carboplatin 69 chemotherapy regimens 69 5 FU 69 mycophenolate mofetil 69 peginterferon 69 zoledronic acid 69 cisplatin 69 azathioprine 69 cytarabine 68 nilotinib 68 lamivudine 68 mitoxantrone 68 chlorambucil 68 DMARDs 68 MabThera 67 pomalidomide 67 tocilizumab 67 FOLFIRI 67 fludarabine 67 FOLFOX 67 irinotecan 67 etoposide 67 fluorouracil 67 carboplatin paclitaxel 67 Taxotere ® 67 lenalidomide 67 dacarbazine 67 cyclophosphamide 67 biologic therapy 67 vandetanib 66 temsirolimus 66 oxaliplatin 66 paclitaxel 66 Bortezomib 66 lapatinib 66 gefitinib 66 leucovorin 66 pegylated interferon 66 capecitabine 66 chronic lymphocytic leukemia CLL 66 bevacizumab Avastin 66 metastatic renal cell carcinoma 66 interferon 66 Taxotere 66 pegylated liposomal doxorubicin 66 anakinra 66 standard chemotherapy regimen 66 imatinib therapy 66 APTIVUS r 65 TNF inhibitors 65 DMARD 65 vinorelbine 65 relapsed refractory 65 TNF inhibitor 65 peginterferon alfa 2a 65 imatinib Gleevec 65 NRTIs 65 nab paclitaxel 65 raltegravir 65 idarubicin 65 natalizumab 65 Fludarabine 65 doxorubicin 65 VELCADE 65 5 fluorouracil 65 milatuzumab 65 daunorubicin 65 ribavirin 65 ofatumumab 65 ritonavir boosted 64 Doxil ® 64 sorafenib Nexavar 64 Tarceva erlotinib 64 indolent NHL 64 Ribavirin 64 chemotherapies 64 chemoradiotherapy 64 Dasatinib 64 glatiramer acetate 64 immunosuppressant 64 PegIFN RBV 64 metastatic RCC 64 tyrosine kinase inhibitor 64 taxanes 64 trabectedin 64 TORISEL 64 rituximab Rituxan 64 advanced NSCLC 64 mapatumumab 64 recurrent GBM 64 dexamethasone 64 letrozole 64 atazanavir 64 low dose cytarabine 64 chemotherapy regimen 64 G CSF 64 Zevalin 64 Peg IFN 64 FOLFOX4 63 abatacept 63 neoadjuvant chemotherapy 63 HER2 positive metastatic breast 63 Gleevec 63 Xeloda 63 chemoradiation 63 galiximab 63 docetaxel Taxotere 63 5FU 63 panitumumab 63 Revlimid 63 PXD# 63 imetelstat 63 Infliximab 63 follicular lymphoma 63 Gemcitabine 63 metastatic colorectal cancer 63 Bevacizumab 63 tipranavir 63 interferon alpha 63 nitazoxanide 63 pazopanib 63 lumiliximab 63 interferon alfa 63 tyrosine kinase inhibitors 63 Vectibix 63 plus ribavirin 63 pertuzumab 63 Cisplatin 63 anti leukemic 63 ZEVALIN 63 Doxil 63 tamoxifen 63 disease modifying antirheumatic 63 ixabepilone 63 Trastuzumab 63 Tarceva 63 Adalimumab 62 ipilimumab 62 pegylated interferon alpha 62 fulvestrant 62 Pegasys ® 62 amrubicin 62 protease inhibitor 62 epirubicin 62 iniparib 62 MabCampath 62 CIMZIA 62 Herceptin trastuzumab 62 clozapine 62 epoetin alfa 62 alemtuzumab 62 Taxotere R 62 Genasense 62 heavily pretreated patients 62 PREZISTA r 62 irbesartan 62 posaconazole 62 alkylating agent 62 ENBREL 62 goserelin 62 perifosine 62 bevacizumab Avastin ® 62 pioglitazone 62 IMGN# 62 chemotherapeutic agents 62 dose dexamethasone 62 DLBCL 62 cytotoxic chemotherapy 62 lenalidomide Revlimid R 62 TACE 62 Velcade 62 gemcitabine Gemzar 62 patients evaluable 62 peg IFN 62 erlotinib Tarceva ® 62 entecavir 62 mRCC 62 Torisel 62 follicular NHL 62 antitumor activity 62 imatinib resistant 62 enfuvirtide 62 anastrozole 62 anthracycline 62 boosted protease inhibitor 62 Cytoxan 62 dexamethasone Decadron 62 epoetin 62 TYKERB 62 clopidogrel 62 free survival PFS 62 Femara 62 FOLPI 62 gefitinib Iressa 62 ACTEMRA 62 interferon therapy 62 darunavir ritonavir 62 ribavirin RBV 62 Erlotinib 61 dose cytarabine 61 Targretin 61 TNF antagonist 61 enzastaurin 61 Irinotecan 61 DAPT 61 chemotherapeutic agent 61 metformin 61 cisplatin chemotherapy 61 Traficet EN 61 INTELENCE 61 pegylated interferon alfa 61 administered subcutaneously 61 T DM1 61 Vidaza 61 REMICADE ® 61 HuMax CD4 61 leukemia CLL 61 Aptivus ® 61 Velcade bortezomib 61 NSCLC 61 nelfinavir 61 immunomodulator 61 Imatinib 61 low dose dexamethasone 61 cilengitide 61 romidepsin 61 MIRCERA 61 darunavir 61 CLL 61 VAPRISOL 61 fosamprenavir 61 Gefitinib 61 imipenem 61 estramustine 61 adalimumab Humira 61 methotrexate MTX 61 fludarabine cyclophosphamide 61 HUMIRA 61 Carboplatin 61 mitomycin 61 cidofovir 61 heavily pretreated 61 visilizumab 61 romiplostim 61 sitagliptin 61 fluconazole 61 clopidogrel Plavix 61 thalidomide Thalomid 61 pegylated interferon alfa 2a 61 pamidronate 61 Telintra 61 bortezomib Velcade 61 Campath 61 pegfilgrastim 61 imatinib mesylate 61 voriconazole 61 cetuximab Erbitux R 61 CIMZIA TM 61 DOXIL 61 CLL SLL 61 uric acid lowering 61 CVP chemotherapy 61 Capecitabine 61 dasatinib Sprycel 61 adjuvant therapy 61 HGS ETR1 61 Amrubicin 61 calcitriol 61 DMARDS 61 axitinib 61 aromatase inhibitor 61 Revlimid lenalidomide 61 erlotinib Tarceva 61 teriflunomide 61 peginterferon alfa 2b 61 peg interferon 60 trastuzumab Herceptin 60 immunotherapy 60 tiotropium 60 idraparinux 60 anthracyclines 60 IFN alpha 60 LEXIVA 60 alpha 2a 60 Treanda 60 5-FU/LV 60 protease inhibitor PI 60 HSCT 60 EGFR TKI 60 baminercept 60 multiple myeloma MM 60 Natalizumab 60 linezolid 60 complete remissions 60 certolizumab 60 oblimersen 60 Mylotarg 60 CoFactor 60 Rituxan MabThera 60 VIDAZA 60 teriparatide 60 relapsed ovarian cancer 60 VICTRELIS 60 Sorafenib 60 evaluable patients 60 hypomethylating agents 60 Hycamtin 60 liposomal doxorubicin 60 paricalcitol 60 cyclophosphamide Cytoxan 60 Cetuximab 60 Cyclophosphamide 60 ERBITUX 60 infliximab Remicade 60 viral kinetics 60 intravenous bisphosphonates 60 relapsing multiple sclerosis 60 lapatinib Tykerb 60 HAART 60 dose escalation 60 fluticasone 60 relapsed CLL 60 ritonavir 60 chemotherapeutic drug 60 cyclophosphamide doxorubicin vincristine 60 adefovir 60 APTIVUS 60 adriamycin 60 alfa 2a 60 oral antiviral 60 peginterferon alfa 60 daclizumab 60 Avastin bevacizumab 60 Avastin 60 taxane 60 achieve sustained virologic 60 strontium ranelate 60 5 Fluorouracil 60 TMC# [001] 60 fondaparinux 60 zalutumumab 60 lupus nephritis 60 bleomycin 60 dacetuzumab 60 chemotherapy docetaxel 60 pregabalin 60 paclitaxel Taxol 60 cabazitaxel 60 docetaxel Taxotere ® 60 N acetylcysteine 60 rituximab refractory 60 atypical antipsychotic 60 lopinavir 60 dose regimens 60 interferon alfa 2a 60 DFMO 60 paclitaxel chemotherapy 60 elotuzumab 60 Tarceva TM 60 complete cytogenetic 60 Herceptin 60 VFEND 60 olmesartan 60 seliciclib 60 tamoxifen therapy 60 efalizumab 60 fluoropyrimidine 60 omalizumab 60 FTY# 60 candesartan 60 REVLIMID 59 sorafenib Nexavar ® 59 relapsed multiple myeloma 59 active comparator 59 allopurinol 59 arsenic trioxide 59 Sandostatin LAR 59 alpha interferon 59 DMARD therapy 59 AZT zidovudine Retrovir 59 plus prednisone 59 relapsed MM 59 cediranib 59 Pemetrexed 59 tenofovir DF 59 peginterferon alfa 2a #KD 59 levosimendan 59 HCV infected 59 STELARA 59 NNRTI 59 cinacalcet 59 Platinol 59 leukemia AML 59 ribavirin therapy 59 sustained virologic response 59 ISENTRESS 59 vancomycin 59 gemcitabine Gemzar ® 59 chronic myeloid leukemia CML 59 YONDELIS 59 CANCIDAS 59 REYATAZ R 59 KRAS status 59 interferon ribavirin 59 XELOX 59 docetaxel Taxotere R 59 clodronate 59 insulin glargine 59 beta interferon 59 Sutent 59 ceftriaxone 59 Alemtuzumab 59 Ofatumumab 59 EGFR inhibitors 59 Nexavar 59 amprenavir 59 vicriviroc 59 paliperidone ER 59 VELCADE melphalan 59 vorinostat 59 sevelamer 59 relapsing remitting multiple sclerosis 59 adjuvant 59 dasatinib Sprycel ® 59 GnRH agonists 59 metastatic melanoma 59 gemcitabine carboplatin 59 azacytidine 59 hA# 59 Abatacept 59 abiraterone 59 elacytarabine 59 dose cohorts 59 FluCAM 59 Folfox 59 BEACOPP 59 CsA 59 BEXXAR 59 Tasigna 59 ramipril 59 gemcitabine chemotherapy 59 ustekinumab 59 tolvaptan 59 Lenalidomide 59 pemetrexed Alimta 59 ganetespib 59 rilonacept 59 interferon IFN 59 intermittent dosing 59 fluvastatin 59 SCH # 59 alefacept 59 BAY #-# 59 pegylated interferon alfa 2b 59 Anti TNF 59 HBeAg positive patients 59 methotrexate therapy 59 FOLFOX6 59 cART 59 Copegus ribavirin 59 amphotericin B 59 gastrointestinal stromal tumors GIST 59 levodopa 59 telaprevir dosed 59 taxane therapy 59 subcutaneous SC 59 metastatic CRC 59 hormonal therapy 59 abiraterone acetate 59 lopinavir r 59 autologous stem cell 59 Platinol ® cisplatin 59 motesanib 59 glufosfamide 59 Epratuzumab 59 antihypertensive agents 59 adecatumumab 59 antipsychotic 59 ULORIC 59 Neulasta ® 59 MGd 59 bicalutamide 59 Cimzia 59 ALIMTA 59 vincristine 59 tyrosine kinase inhibitor TKI 59 interferon alfa 2b 59 valopicitabine 59 immunosuppressive agents 59 ACZ# 59 Rituxan rituximab 59 memantine 59 OncoVEX GM CSF 59 anti TNF alpha 59 thymalfasin 59 melphalan prednisone 59 metastatic malignant 58 valsartan 58 Etanercept 58 CellCept 58 μg dose 58 standard chemotherapy regimens 58 talabostat 58 sipuleucel T 58 RoACTEMRA 58 Pegasys peginterferon alfa 2a 58 ZD# [001] 58 virologic 58 tigecycline 58 COPAXONE R 58 Campath alemtuzumab 58 PEG IFN 58 telbivudine 58 cetuximab Erbitux ® 58 trastuzumab Herceptin ® 58 Actemra 58 antiangiogenic therapy 58 octreotide LAR 58 Oxaliplatin 58 PLX# 58 ACTEMRA TM 58 anticancer therapy 58 neoadjuvant therapy 58 sirolimus 58 HAART regimen 58 blinatumomab 58 protease inhibitors 58 lintuzumab 58 SUTENT 58 Clolar 58 mTOR inhibitor 58 Halaven 58 sapacitabine 58 clofarabine 58 chemotherapy gemcitabine 58 simvastatin 58 NRTI 58 Protelos 58 HuMax CD# 58 cytogenetic responses 58 tacrolimus ointment 58 Teriflunomide 58 surrogate endpoint 58 Pegasys 58 ASA# 58 tolerability 58 Dapagliflozin 58 Tykerb 58 mcg kg 58 refractory CLL 58 antithrombotic 58 evaluable 58 HGS# 58 Atacand 58 tipranavir ritonavir 58 leukotriene receptor antagonist 58 Allovectin 7 ® 58 TREANDA 58 PKC# 58 bosentan 58 chemotherapy 58 paclitaxel Taxol R 58 ZYVOX 58 Free Survival PFS 58 Pegasys plus Copegus 58 neratinib 58 aflibercept 58 sunitinib malate 58 receiving VICTRELIS 58 IFN beta 58 IRESSA 58 antihypertensive drugs 58 eplerenone 58 imatinib mesylate Gleevec 58 octreotide 58 mTOR inhibitors 58 pyrazinamide 58 neoadjuvant 58 CA4P 58 celecoxib 58 TKI therapy 58 rhEPO 58 Jevtana 58 RG# [001] 58 AZILECT 58 antiviral therapy 58 CLL cells 58 plus dexamethasone 58 aprepitant 58 Interferon 58 cell lymphoma CTCL 58 febuxostat 58 doxorubicin cyclophosphamide 58 neoadjuvant treatment 58 disease progression 58 Gleevec imatinib 58 rFVIIa 58 plus methotrexate 58 AGILECT R 58 Zolinza 58 HAART regimens 58 Xanafide 58 xenograft models 58 tumor shrinkage 58 interferon beta 58 Hodgkin lymphoma NHL 58 aliskiren 58 cytogenetic response 58 eribulin 58 Methotrexate 58 tacrolimus 58 Lapatinib 58 IMC A# 58 Gleevec resistant 58 TAXOTERE R 58 Amigal 58 corticosteroid 58 picoplatin 58 platinum refractory 58 neurologic progression 58 Peginterferon 58 ibandronate 58 PEG Interferon lambda 58 bisphosphonate 58 calcineurin inhibitors 58 dexrazoxane 58 taxane chemotherapy 58 cytarabine daunorubicin 58 Docetaxel 58 ORENCIA 58 LPV r 58 immunomodulatory therapy 58 PROMACTA 58 Gemzar ® 58 biologic DMARD 58 relapsed SCLC 58 refractory AML 58 Dacogen injection 58 INCB# [001] 58 adjuvant chemotherapy 58 PEGINTRON 58 previously untreated follicular 58 ezetimibe 58 superficial bladder cancer 58 quetiapine 58 virologic failure 58 gemcitabine cisplatin 58 ocrelizumab 58 therapeutic regimens 58 certolizumab pegol 58 Virologic 58 GVAX 58 concurrent chemoradiation 58 peginterferon alpha 2a 58 XmAb# 58 NeoRecormon 58 integrase inhibitor 58 Laquinimod 58 remission induction 58 Tipranavir 58 MabThera rituximab 58 paclitaxel carboplatin 58 telaprevir 58 #mg/m# [002] 58 nucleoside analogs 58 Darunavir 58 chemotherapeutic regimens 58 ZOLINZA 58 hydroxyurea 57 chemotherapeutic regimen 57 depsipeptide 57 chemo radiotherapy 57 rhTSH 57 mCRC patients 57 tanespimycin 57 sustained virological response 57 Imprime PGG 57 LHRH 57 SPRYCEL ® 57 Cimzia ® 57 pegylated 57 Taxotere docetaxel 57 dosing schedules 57 preoperative chemotherapy 57 unresectable 57 selegiline 57 Epivir 57 LMWH 57 placebo dexamethasone 57 dosage regimens 57 Arranon 57 leflunomide 57 methylnaltrexone 57 Phase Ib II 57 TNF antagonists 57 Gleevec imatinib mesylate 57 Pegylated Interferon 57 FOLFIRINOX 57 HRPC 57 sunitinib Sutent 57 eculizumab 57 Dacogen 57 tenofovir Viread 57 dosing intervals 57 ACE inhibitor 57 BARACLUDE ® 57 virologic response 57 statins 57 CRp 57 LEXIVA r 57 hydroxychloroquine 57 antidepressant therapy 57 chemotherapeutic drugs 57 anti TNFs 57 anti VEGF 57 postoperative chemotherapy 57 abatacept Orencia 57 recurrent glioblastoma multiforme 57 achieved ACR# 57 rituximab Rituxan ® 57 lamotrigine 57 imiquimod 57 Certolizumab pegol 57 LY# [003] 57 mg kg dose 57 carvedilol 57 Pharmacokinetics PK 57 Interferon alpha 57 androgen deprivation 57 montelukast 57 MGCD# [001] 57 bisphosphonates 57 NNRTIs 57 complete cytogenetic response 57 mg BID 57 EGFR tyrosine kinase inhibitors 57 GRN#L 57 bortezomib Velcade R 57 AEGR 57 Leukine 57 FOLOTYN 57 TELCYTA 57 Myelodysplastic Syndrome MDS 57 reboxetine 57 abacavir lamivudine 57 trastuzumab Herceptin R 57 VEGF inhibitors 57 afatinib 57 Arixtra 57 eniluracil 57 PegIntron 57 solid tumors 57 rindopepimut 57 olaparib 57 PSMA ADC 57 pegylated interferons 57 Tamibarotene 57 AVASTIN 57 oral rivaroxaban 57 belatacept 57 APTIVUS R 57 TEMODAL 57 cardiac toxicity 57 triamcinolone 57 IGIV 57 custirsen 57 trabedersen 57 HBeAg negative patients 57 progression TTP 57 celgosivir 57 Iressa 57 maraviroc 57 atazanavir ritonavir 57 Proleukin 57 rapamycin 57 BMS # 57 canakinumab 57 melphalan 57 HuMax EGFr 57 Taxol 57 antitumor effect 57 everolimus 57 Xcytrin 57 adjuvant tamoxifen 57 Ontak 57 infusional 5-FU/LV 57 belinostat 57 brentuximab vedotin 57 antiviral efficacy 57 risedronate 57 insulin detemir 57 Interferon alfa 57 S/GSK# 57 cholinesterase inhibitor 57 treatment regimens 57 Nilotinib 57 caspofungin 57 PEGylated Fab fragment 57 tamsulosin 57 evaluating tivozanib 57 TRIZIVIR 57 eltrombopag 57 8mg/kg 57 panitumumab Vectibix 57 #mg/m# [001] 57 Cimzia R 57 splenectomized patients 57 TYGACIL 57 CYT# 57 dabigatran etexilate 57 angiogenesis inhibitor 57 multiple myeloma 57 antitumor 57 tiotropium bromide 57 FUZEON 57 B CLL 57 OADs 57 angiotensin receptor blocker ARB 57 dose interleukin 57 fingolimod 57 achieved PASI 57 Bezielle 57 Omacetaxine 57 immunomodulatory 57 phenoxodiol 57 interferon gamma 1b 57 SPRYCEL 57 BRAF mutation 57 Pazopanib 57 tamibarotene 57 diagnosed multiple myeloma 57 mitoxantrone chemotherapy 57 interferon beta 1a 57 oral antidiabetic 57 rt PA 57 Pertuzumab 57 mg ustekinumab 57 ISTODAX 57 L dopa 57 BRAF inhibitor 57 mg/m2/day 57 losartan 57 gastrointestinal stromal tumor GIST 57 bosutinib 57 achieved sustained virologic 57 Aflibercept 57 CD# monoclonal antibody 57 metastatic malignant melanoma 57 pramipexole 57 xanthine oxidase inhibitor 57 TNF alpha inhibitor 57 subcutaneously administered 57 IRX 2 57 Ceplene/IL-2 57 pyridostigmine 57 zidovudine lamivudine 57 Vfend 57 Boceprevir 57 intravesical 57 ara C 57 antihypertensive therapy 57 lenalidomide dexamethasone 57 mirtazapine 57 proteasome inhibitors 57 Zometa 57 rHuPH# 57 antiviral 57 anthracycline taxane 57 tumor regression 57 seropositive patients 57 dutasteride 57 3TC 57 MabThera Rituxan 57 TKIs 57 cyclophosphamide methotrexate 57 odanacatib 57 carfilzomib 57 HBeAg positive 57 FOSRENOL ® 57 etanercept Enbrel 57 Tocilizumab 57 Yervoy 57 ONTAK 57 intravenously administered 57 Pegintron 57 gastrointestinal stromal tumors 57 nucleoside reverse transcriptase inhibitors 57 T#I [002] 57 Valcyte 57 Hycamtin ® 57 Sunitinib 56 BRIM2 56 belimumab 56 IFN α 56 epratuzumab 56 levetiracetam 56 capecitabine Xeloda 56 tinidazole 56 metastatic hormone refractory 56 colorectal liver metastases 56 disease modifying 56 CAELYX 56 Combination therapy 56 imatinib Gleevec ® 56 cobicistat 56 lopinavir ritonavir 56 KRN# 56 bezafibrate 56 Erbitux 56 tipifarnib 56 Aclasta 56 invasive candidiasis 56 mCRC 56 cyclosporin 56 miglustat 56 antiplatelet 56 Ceflatonin 56 intravenous immunoglobulin 56 TNF alpha inhibitors 56 mutated KRAS 56 Pralatrexate 56 peginterferon alfa 2a Pegasys 56 budesonide 56 ABVD 56 RAD# [003] 56 tenofovir emtricitabine 56 RITUXAN 56 timolol 56 nilotinib Tasigna 56 febrile neutropenia 56 EGFR TKIs 56 statin 56 metastatic GIST 56 paclitaxel Taxol ® 56 sertraline 56 vismodegib 56 doxorubicin HCl liposome injection 56 Telcyta 56 CIMZIA ™ 56 meropenem 56 randomized Phase III 56 moxifloxacin 56 citalopram 56 Roche Pegasys 56 TELINTRA 56 fibrinolytic 56 cytotoxic 56 donepezil 56 mertansine 56 amiodarone 56 PEGPH# 56 Alkeran 56 micafungin 56 piperacillin tazobactam 56 temozolomide TMZ 56 LHRH agonists 56 thalidomide dexamethasone 56 REBETOL 56 YERVOY 56 oral Xeloda 56 APOPTONE 56 amifostine 56 etravirine 56 partial remissions 56 postmenopausal osteoporotic women 56 forodesine 56 #mg dose [001] 56 radioimmunotherapy 56 stavudine 56 atorvastatin 56 metastatic lung cancer